ELENBECESTAT, E2609, A BACE INHIBITOR: RESULTS FROM A PHASE-2 STUDY IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT AND MILD-TO-MODERATE DEMENTIA DUE TO ALZHEIMER'S DISEASE
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
17
Citations
NaN
KQI